pH-triggered drug release from biodegradable microwells for oral drug delivery

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

pH-triggered drug release from biodegradable microwells for oral drug delivery. / Nielsen, Line Hagner; Nagstrup, Johan; Gordon, Sarah; Keller, Stephan Sylvest; Østergaard, Jesper; Rades, Thomas; Müllertz, Anette; Boisen, Anja.

In: Biomedical Microdevices, Vol. 17, 55, 06.2015.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nielsen, LH, Nagstrup, J, Gordon, S, Keller, SS, Østergaard, J, Rades, T, Müllertz, A & Boisen, A 2015, 'pH-triggered drug release from biodegradable microwells for oral drug delivery', Biomedical Microdevices, vol. 17, 55. https://doi.org/10.1007/s10544-015-9958-5

APA

Nielsen, L. H., Nagstrup, J., Gordon, S., Keller, S. S., Østergaard, J., Rades, T., Müllertz, A., & Boisen, A. (2015). pH-triggered drug release from biodegradable microwells for oral drug delivery. Biomedical Microdevices, 17, [55]. https://doi.org/10.1007/s10544-015-9958-5

Vancouver

Nielsen LH, Nagstrup J, Gordon S, Keller SS, Østergaard J, Rades T et al. pH-triggered drug release from biodegradable microwells for oral drug delivery. Biomedical Microdevices. 2015 Jun;17. 55. https://doi.org/10.1007/s10544-015-9958-5

Author

Nielsen, Line Hagner ; Nagstrup, Johan ; Gordon, Sarah ; Keller, Stephan Sylvest ; Østergaard, Jesper ; Rades, Thomas ; Müllertz, Anette ; Boisen, Anja. / pH-triggered drug release from biodegradable microwells for oral drug delivery. In: Biomedical Microdevices. 2015 ; Vol. 17.

Bibtex

@article{ad3198a0d59d40acb0ae53d065686c8b,
title = "pH-triggered drug release from biodegradable microwells for oral drug delivery",
abstract = "Microwells fabricated from poly-L-lactic acid (PLLA) were evaluated for their application as an oral drug delivery system using the amorphous sodium salt of furosemide (ASSF) as a model drug. Hot embossing of PLLA resulted in fabrication of microwells with an inner diameter of 240 μm and a height of 100 μm. The microwells were filled with ASSF using a modified screen printing technique, followed by coating of the microwell cavities with a gastro-resistant lid of Eudragit{\textregistered} L100. The release behavior of ASSF from the coated microwells was investigated using a μ-Diss profiler and a UV imaging system, and under conditions simulating the changing environment of the gastrointestinal tract. Biorelevant gastric medium (pH 1.6) was employed, after which a change to biorelevant intestinal release medium (pH 6.5) was carried out. Both μ-Diss profiler and UV imaging release experiments showed that sealing of microwell cavities with an Eudragit{\textregistered} layer prevented drug release in biorelevant gastric medium. An immediate release of the ASSF from coated microwells was observed in the intestinal medium. This pH-triggered release behavior demonstrates the future potential of PLLA microwells as a site-specific oral drug delivery system.",
author = "Nielsen, {Line Hagner} and Johan Nagstrup and Sarah Gordon and Keller, {Stephan Sylvest} and Jesper {\O}stergaard and Thomas Rades and Anette M{\"u}llertz and Anja Boisen",
year = "2015",
month = jun,
doi = "10.1007/s10544-015-9958-5",
language = "English",
volume = "17",
journal = "Biomedical Microdevices",
issn = "1387-2176",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - pH-triggered drug release from biodegradable microwells for oral drug delivery

AU - Nielsen, Line Hagner

AU - Nagstrup, Johan

AU - Gordon, Sarah

AU - Keller, Stephan Sylvest

AU - Østergaard, Jesper

AU - Rades, Thomas

AU - Müllertz, Anette

AU - Boisen, Anja

PY - 2015/6

Y1 - 2015/6

N2 - Microwells fabricated from poly-L-lactic acid (PLLA) were evaluated for their application as an oral drug delivery system using the amorphous sodium salt of furosemide (ASSF) as a model drug. Hot embossing of PLLA resulted in fabrication of microwells with an inner diameter of 240 μm and a height of 100 μm. The microwells were filled with ASSF using a modified screen printing technique, followed by coating of the microwell cavities with a gastro-resistant lid of Eudragit® L100. The release behavior of ASSF from the coated microwells was investigated using a μ-Diss profiler and a UV imaging system, and under conditions simulating the changing environment of the gastrointestinal tract. Biorelevant gastric medium (pH 1.6) was employed, after which a change to biorelevant intestinal release medium (pH 6.5) was carried out. Both μ-Diss profiler and UV imaging release experiments showed that sealing of microwell cavities with an Eudragit® layer prevented drug release in biorelevant gastric medium. An immediate release of the ASSF from coated microwells was observed in the intestinal medium. This pH-triggered release behavior demonstrates the future potential of PLLA microwells as a site-specific oral drug delivery system.

AB - Microwells fabricated from poly-L-lactic acid (PLLA) were evaluated for their application as an oral drug delivery system using the amorphous sodium salt of furosemide (ASSF) as a model drug. Hot embossing of PLLA resulted in fabrication of microwells with an inner diameter of 240 μm and a height of 100 μm. The microwells were filled with ASSF using a modified screen printing technique, followed by coating of the microwell cavities with a gastro-resistant lid of Eudragit® L100. The release behavior of ASSF from the coated microwells was investigated using a μ-Diss profiler and a UV imaging system, and under conditions simulating the changing environment of the gastrointestinal tract. Biorelevant gastric medium (pH 1.6) was employed, after which a change to biorelevant intestinal release medium (pH 6.5) was carried out. Both μ-Diss profiler and UV imaging release experiments showed that sealing of microwell cavities with an Eudragit® layer prevented drug release in biorelevant gastric medium. An immediate release of the ASSF from coated microwells was observed in the intestinal medium. This pH-triggered release behavior demonstrates the future potential of PLLA microwells as a site-specific oral drug delivery system.

U2 - 10.1007/s10544-015-9958-5

DO - 10.1007/s10544-015-9958-5

M3 - Journal article

C2 - 25981751

VL - 17

JO - Biomedical Microdevices

JF - Biomedical Microdevices

SN - 1387-2176

M1 - 55

ER -

ID: 144456645